Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oblimersen and Doxorubicin in Advanced Hepatocellular Carcinoma
NCT00047229Phase 2Completed
- Sponsor
- University Health Network
- Start
- Oct 2002
- Primary completion
- Jan 2009
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 2 trial of oblimersen in hepatocellular carcinoma (HCC), sponsored by University Health Network. Started Oct 2002; status: completed.
02
Drugs
oblimersen
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00047229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047229.